Hepatitis C
From Guide to YKHC Medical Practices
Anyone with untreated Hepatitis C (HCV) can be given glecaprevir/pibrentasvir (Mavyret™) for 8 weeks.
Please call the ANMC Hepatology team with any questions and see the Resources below for a link to the Prior Authorization Form.
If a patient is to be started on glecaprevir/pibrentasvir, the medication prior authorization form needs to be filled out by BOTH patient and provider prior to the medication being dispensed. It is ideal to have this form completed during the visit and given to your clinic pharmacist when sending the prescription to the pharmacy.
